Human Epidermal Growth Factor Receptor 2-Positive Duodenal Adenocarcinoma: A Case Report and Review of the Literature

Duodenal adenocarcinoma is a rare malignancy and carries a poor prognosis. The role of adjuvant therapy and the optimal chemotherapy regimen remain largely unclear. Treatment with trastuzumab results in prolonged survival in gastroesophageal cancer if human epidermal growth factor receptor 2 (HER2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Braga, Virginia Moreira, de Oliveira, Marcos Belotto, Netto, Caio Coelho, Ibrahim, Roberto El, Peixoto, Renata D'Alpino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: July, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560331/
https://www.ncbi.nlm.nih.gov/pubmed/26351435
http://dx.doi.org/10.1159/000437257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560331/
https://www.ncbi.nlm.nih.gov/pubmed/26351435
http://dx.doi.org/10.1159/000437257

Ejemplares similares